Financhill
Sell
25

HOWL Quote, Financials, Valuation and Earnings

Last price:
$0.61
Seasonality move :
10.2%
Day range:
$0.61 - $0.67
52-week range:
$0.56 - $2.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
52.13x
P/B ratio:
1.07x
Volume:
670K
Avg. volume:
765.7K
1-year change:
-58.85%
Market cap:
$31.8M
Revenue:
$1.9M
EPS (TTM):
-$1.62

Earnings Data

Next earnings date for HOWL
Mar 10
2026
Most recent earnings per share
-$0.36
Beat by $0.03
(Nov 4/2025)
Consensus Estimate
-$0.38
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HOWL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 -- -- -- -$0.35 --
11/04/2025 Q3 -- -- -$0.36 -$0.38 $0.03
08/14/2025 Q2 -- -- -$0.40 -$0.37 -$0.03
05/09/2025 Q1 $300K -- -$0.40 -$0.43 $0.03
03/11/2025 Q4 $301.6K -- -$0.46 -$0.31 -$0.15
11/07/2024 Q3 $709.3K -- -$0.38 -$0.39 $0.01
08/08/2024 Q2 $841.8K $1.1M -$0.43 -$0.39 -$0.04
05/03/2024 Q1 $1.5M $742K -$0.39 -$0.34 -$0.05
03/07/2024 Q4 $1.9M $1.5M -$0.33 -$0.41 $0.08
11/14/2023 Q3 -- -- -$0.23 -$0.35 $0.12
08/10/2023 Q2 -- -- -$0.14 -$0.40 $0.26
05/11/2023 Q1 -- -- -$0.34 -$0.46 $0.12
03/23/2023 Q4 -- -- -$0.39 -$0.51 $0.12
11/10/2022 Q3 -- -- -$0.40 -$0.56 $0.16
08/11/2022 Q2 -- -- -$0.53 -$0.60 $0.07
05/10/2022 Q1 -- -- -$0.56 -$0.58 $0.02
03/24/2022 Q4 -- -- -$0.66 -$0.53 -$0.13
11/10/2021 Q3 -- -- -$0.51 -$0.46 -$0.05
08/12/2021 Q2 -- -- -$3.82 -$0.28 -$3.54
06/10/2021 Q1 -- -- -$3.90 -$0.43 -$3.47
12/31/2020 Q4 -- -- -$0.82 -- --
03/31/2020 Q1 -- -- -$0.43 -- --

Werewolf Therapeutics, Inc. Earnings Questions

  • How Much did Werewolf Therapeutics, Inc. Generate in Revenue Last Quarter?

    Werewolf Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Werewolf Therapeutics, Inc. Beat Earnings Last Quarter?

    Werewolf Therapeutics, Inc. announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.38 per share.

  • Is Werewolf Therapeutics, Inc. Profitable?

    Werewolf Therapeutics, Inc. reported -$402K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Werewolf Therapeutics, Inc. EPS Next Year?

    Werewolf Therapeutics, Inc.'s earnings are forecast to decrease from -$1.63 per share to -$1.42 per share next year representing a decrease of -9.4%.

  • When is Werewolf Therapeutics, Inc.'s Earnings Date?

    Werewolf Therapeutics, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 12.13% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock